Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Lourdes PérezDepartment of Surfactants and Nanobiotechnology, Instituto de Química Avanzada de Cataluña, Consejo Superior de Investigaciones Químicas (IQAC-CSIC), 08034 Barcelona, Spain.ORCID 0000-0002-3696-021X
Cecília Rocha da SilvaLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Lívia Gurgel do Amaral Valente SáLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.ORCID 0000-0002-0619-2782
João Batista de Andrade NetoLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Vitória Pessoa de Farias CabralLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.ORCID 0000-0002-6408-7200
Daniel Sampaio RodriguesLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.ORCID 0000-0001-8496-8243
Lara Elloyse Almeida MoreiraLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Maria Janielly Castelo Branco SilveiraLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.ORCID 0000-0001-7613-5671
Thais Lima FerreiraLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Anderson Ramos da SilvaDepartment of Surfactants and Nanobiotechnology, Instituto de Química Avanzada de Cataluña, Consejo Superior de Investigaciones Químicas (IQAC-CSIC), 08034 Barcelona, Spain.
Bruno Coêlho CavalcantiCenter of Drug Research and Development, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Nágila Maria Pontes Silva RicardoPolymer and Materials Innovation Laboratory (LABPIM), Department of Organic and Inorganic Chemistry, Sciences Center, Federal University of Ceará, Fortaleza 60440-900, Brazil.ORCID 0000-0003-1849-5403
Francisco Alessandro Marinho RodriguesPolymer and Materials Innovation Laboratory (LABPIM), Department of Organic and Inorganic Chemistry, Sciences Center, Federal University of Ceará, Fortaleza 60440-900, Brazil.ORCID 0000-0002-8130-2435
Hélio Vitoriano Nobre JúniorLaboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), School of Pharmacy, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Funding
CNPq/MCTI/CT - Health - Actions in Science, Technology, and Innovation to Combat Antimi-crobial Resistance, Call no 52/2022MCIN/AEI/10.13039/501100011033 Grant PID2022-136354-NBI00
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Preventive Activity of an Arginine-Based Surfactant on the Formation of Mixed Biofilms of Fluconazole-Resistant · full record | Socratic